Short-term clinical outcomes of acute treatment of childhood asthma.
OBJECTIVE
Acute exacerbations of asthma are the leading cause of emergency department visits in the pediatric patient. The present review is focused on the identification of those factors that may contribute to improving the short-term outcome of children after discharge from an emergency department visit for acute asthma.


RESULTS
Several recent studies have documented that children treated at the emergency department because of an asthma-related event present a high morbidity at 7 and 15 days after discharge, mainly associated with symptom persistence, need for rescue bronchodilator medication, and absenteeism from school or day nursery. A better control of the disease, particularly adequate outpatient follow-up and maintenance treatment with inhaled steroids, could improve short-term clinical outcomes.


CONCLUSIONS
All efforts of emergency room management of children with asthma, identification of severity of the current exacerbation episode, and intensive treatment of the acute asthma attack have usually been directed at reducing the rates of hospitalization and the return for medical care. However, according to reported data on short-term morbidity, it is necessary to define therapeutic and follow-up strategies after treatment for acute asthma and emergency department discharge. Besides standard treatment for an acute asthma exacerbation in a pediatric emergency department, action plans should include a review of the maintenance treatment of asthma to improve underlying disease control and a strong recommendation for close follow-up by the primary care pediatrician.
Benito-Fernández
Javier
J
Department of Pediatrics, Basque Country University, Hospital de Cruces, Barakaldo, Bizkaia, Spain. jbenito@hcru.osakidetza.net
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004632:Emergency Medical Services / Q000379:methods*; D006801:Humans; D007223:Infant; D009017:Morbidity; D011788:Quality of Life; D016896:Treatment Outcome
D018927:Anti-Asthmatic Agents